BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22751465)

  • 1. Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.
    Zhang M; Mathur A; Zhang Y; Xi S; Atay S; Hong JA; Datrice N; Upham T; Kemp CD; Ripley RT; Wiegand G; Avital I; Fetsch P; Mani H; Zlott D; Robey R; Bates SE; Li X; Rao M; Schrump DS
    Cancer Res; 2012 Aug; 72(16):4178-92. PubMed ID: 22751465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoke promotes drug resistance and expansion of cancer stem cell-like side population.
    An Y; Kiang A; Lopez JP; Kuo SZ; Yu MA; Abhold EL; Chen JS; Wang-Rodriguez J; Ongkeko WM
    PLoS One; 2012; 7(11):e47919. PubMed ID: 23144836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.
    Yang WJ; Song MJ; Park EY; Lee JJ; Park JH; Park K; Park JH; Kim HP
    Mol Cells; 2013 Oct; 36(4):368-75. PubMed ID: 23996530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.
    Wang F; Mi YJ; Chen XG; Wu XP; Liu Z; Chen SP; Liang YJ; Cheng C; To KK; Fu LW
    Mol Med; 2012 Jul; 18(1):887-98. PubMed ID: 22549112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells.
    Wang XK; He JH; Xu JH; Ye S; Wang F; Zhang H; Huang ZC; To KK; Fu LW
    Cancer Res; 2014 Aug; 74(16):4431-45. PubMed ID: 24972892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate.
    Wang L; Liu L; Chen Y; Du Y; Wang J; Liu J
    Pathol Res Pract; 2018 Sep; 214(9):1467-1473. PubMed ID: 30104076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
    Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
    Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation.
    Niu Q; Wang W; Li Y; Ruden DM; Wang F; Li Y; Wang F; Song J; Zheng K
    PLoS One; 2012; 7(7):e41035. PubMed ID: 22844424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties
    Xie C; Zhu J; Jiang Y; Chen J; Wang X; Geng S; Wu J; Zhong C; Li X; Meng Z
    Theranostics; 2019; 9(16):4827-4840. PubMed ID: 31367260
    [No Abstract]   [Full Text] [Related]  

  • 13. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells.
    To KK; Yu L; Liu S; Fu J; Cho CH
    Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway.
    To KK; Robey R; Zhan Z; Bangiolo L; Bates SE
    Mol Cancer Res; 2011 Apr; 9(4):516-27. PubMed ID: 21357443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
    Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
    Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
    Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
    Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
    Hou H; Sun H; Lu P; Ge C; Zhang L; Li H; Zhao F; Tian H; Zhang L; Chen T; Yao M; Li J
    Mol Cancer Ther; 2013 Dec; 12(12):2874-84. PubMed ID: 24130050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
    Li F; Zeng H; Ying K
    Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel xenobiotic responsive element regulated by aryl hydrocarbon receptor is involved in the induction of BCRP/ABCG2 in LS174T cells.
    Tompkins LM; Li H; Li L; Lynch C; Xie Y; Nakanishi T; Ross DD; Wang H
    Biochem Pharmacol; 2010 Dec; 80(11):1754-61. PubMed ID: 20804740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
    Liu L; Ju Y; Wang J; Zhou R
    Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.